Komori
Creema (4017) · RiskDropped

Gradual Easing of the Impact of COVID-19 Based on Vaccine Rollout

First written in FY2022-Q1. 4 of 7 entries say "Restated". Latest entry: FY2023.

7entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022-Q1RestatedFY2022-Q3 – FY20232021: 220212022: 320222023: 22023
Same theme, other companies
Accounting Estimates Based on Assumptions Regarding COVID-19A theme 597 companies write about · 468 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 5 of 22 companies on the "Worse" side.

65 other companies' latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 600 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2023DroppedAnnual report
    This filing does not state the accounting estimate assumption that the impact would ease from around August 2021 as vaccines became more widely available. The key accounting estimates have been replaced by the valuation of software.
  2. FY2023-Q3RestatedAnnual report

    「Although it is difficult to accurately predict how the COVID-19 pandemic will spread or when it will subside, the Group has made accounting estimates, including the recoverability of deferred tax assets and impairment accounting for fixed assets, on the assumption that the impact on social and economic activity, including requests to refrain from going out and holding events, will gradually ease as vaccines become more widely available.」

    The company continues to use, in its accounting estimates, the assumption that although the impact of the pandemic is difficult to predict, it will gradually ease as vaccines become more widely available.
  3. FY2023-Q2RestatedAnnual report

    「Although it is difficult to accurately predict how the COVID-19 pandemic will spread or when it will subside, the Group has made accounting estimates, including the recoverability of deferred tax assets and impairment accounting for fixed assets, on the assumption that the impact on social and economic activity, including requests to refrain from going out and holding events, will gradually ease as vaccines become more widely available.」

    The company continues to use, in its accounting estimates, the assumption that although the impact of the pandemic is difficult to predict, it will gradually ease as vaccines become more widely available.
  4. FY2023-Q1RestatedAnnual report

    「Although it is difficult to accurately predict how the COVID-19 pandemic will spread or when it will subside, the Group has made accounting estimates, including the recoverability of deferred tax assets and impairment accounting for fixed assets, on the assumption that the impact on social and economic activity, including requests to refrain from going out and holding events, will gradually ease as vaccines become more widely available.」

    The company continues to use, in its accounting estimates, the assumption that although the impact of the pandemic is difficult to predict, it will gradually ease as vaccines become more widely available.
  5. FY2022-Q3RestatedAnnual report

    「Although it is difficult to accurately predict how the COVID-19 pandemic will spread or when it will subside, the Group has made accounting estimates, including the recoverability of deferred tax assets and impairment accounting for fixed assets, on the assumption that the impact on social and economic activity, including requests to refrain from going out and holding events, will gradually ease as vaccines become more widely available.」

    The company continues to use, in its accounting estimates, the assumption that although the impact of COVID-19 is difficult to predict, it will gradually ease as vaccines become more widely available.
  6. FY2022-Q2SoftenedAnnual report

    「Although it is difficult to accurately predict how the COVID-19 pandemic will spread or when it will subside, the Group has made accounting estimates, including the recoverability of deferred tax assets and impairment accounting for fixed assets, on the assumption that the impact on social and economic activity, including requests to refrain from going out and holding events, will gradually ease as vaccines become more widely available.」

    The specific timing stated in the previous quarter, “around August 2021,” has been removed, and the wording now states that the impact will ease “gradually” as vaccines become more widely available.
  7. FY2022-Q1First statedAnnual report

    「Although it is difficult to accurately predict how COVID-19 will spread or when it will subside, the Company has made accounting estimates, including the recoverability of deferred tax assets and impairment accounting for fixed assets, on the assumption that the impact on social and economic activity, including requests to refrain from going out and holding events, will gradually ease around August 2021 as vaccines become more widely available.」

    The Company uses the assumption that the impact of COVID-19 will gradually ease around August 2021 as vaccines become more widely available when making accounting estimates for deferred tax assets and impairment of fixed assets.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Creema yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Gradual Easing of the Impact of COVID-19 Based on Vaccine Rollout | CREEMA LTD. (4017) | Komori